Efficacy and Safety of Prophylactic High-Dose MTX in High-Risk DLBCL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Prophylactic High-Dose MTX in High-Risk DLBCL: A Treatment Intent-Based Analysis
Blood Adv 2021 Apr 27;5(8)2142-2152, H Jeong, H Cho, H Kim, H Chae, JB Lee, K Lee, S Kim, SW Lee, JS Ryu, KW Kim, EJ Chae, J Huh, CS Park, DH Yoon, C SuhFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.